Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- ChecktodayChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedUpdated the location entry from Padua, Italy 35128 to Padova, Italy 35128 in the trial locations.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows Revision: v3.4.1 replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.